Aker BioMarine ASA (OSL:AKBM)
Norway · Delayed Price · Currency is NOK 97.30
-2.70 (-2.70%)
Jul 10, 2026, 4:25 PM CET
Aker BioMarine ASA Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 227.2 | 218.1 | 199 | 196.3 | 277.2 | 262.1 |
| 227.2 | 218.1 | 199 | 196.3 | 277.2 | 262.1 | |
Revenue Growth (YoY) | 9.55% | 9.60% | 1.38% | -29.18% | 5.76% | -9.18% |
Cost of Revenue | 124.9 | 120.3 | 120.6 | 123.8 | 162.4 | 174 |
Gross Profit | 102.3 | 97.8 | 78.4 | 72.5 | 114.8 | 88.1 |
Selling, General & Admin | 70.3 | 69.1 | 68 | 66.4 | 86.5 | 84.3 |
Other Operating Expenses | -0.9 | -2 | -1 | 0.1 | -4.4 | -2.7 |
Operating Expenses | 87.5 | 85 | 82.4 | 82.8 | 98.5 | 95 |
Operating Income | 14.8 | 12.8 | -4 | -10.3 | 16.3 | -6.9 |
Interest Expense | -22.7 | -13.9 | -2.5 | -19.7 | -20.3 | -13.7 |
Interest & Investment Income | 1 | 1 | 3.6 | 1.5 | 0.6 | - |
Earnings From Equity Investments | -2.4 | -2.4 | - | -3 | - | - |
Currency Exchange Gain (Loss) | 1.1 | 1.1 | -1 | -0.8 | 8.1 | 0.6 |
Other Non Operating Income (Expenses) | -1.2 | -1.3 | -8.1 | - | -1.7 | -1.7 |
EBT Excluding Unusual Items | -9.4 | -2.7 | -12 | -32.3 | 3 | -21.7 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.4 |
Asset Writedown | -0.1 | -0.1 | -1.2 | - | - | -5.8 |
Other Unusual Items | - | - | - | - | 9.2 | 19.7 |
Pretax Income | -9.5 | -2.8 | -12.1 | -32.3 | 12.2 | -7.4 |
Income Tax Expense | 0.5 | - | -0.1 | - | 2.2 | 0.6 |
Earnings From Continuing Operations | -10 | -2.8 | -12 | -32.3 | 10 | -8 |
Earnings From Discontinued Operations | -3.3 | -20 | 194.6 | 23.3 | - | - |
Net Income | -13.3 | -22.8 | 182.6 | -9 | 10 | -8 |
Net Income to Common | -13.3 | -22.8 | 182.6 | -9 | 10 | -8 |
Shares Outstanding (Basic) | 87 | 88 | 88 | 88 | 88 | 88 |
Shares Outstanding (Diluted) | 87 | 88 | 88 | 88 | 88 | 88 |
Shares Change (YoY) | -0.01% | 0.02% | 0.02% | 0.04% | 0.05% | 12.20% |
EPS (Basic) | -0.15 | -0.26 | 2.08 | -0.10 | 0.11 | -0.09 |
EPS (Diluted) | -0.15 | -0.26 | 2.08 | -0.10 | 0.11 | -0.09 |
Free Cash Flow | -13.9 | -2.1 | -5.2 | 1.5 | -25.4 | -76.1 |
Free Cash Flow Per Share | -0.16 | -0.02 | -0.06 | 0.02 | -0.29 | -0.87 |
Gross Margin | 45.03% | 44.84% | 39.40% | 36.93% | 41.41% | 33.61% |
Operating Margin | 6.51% | 5.87% | -2.01% | -5.25% | 5.88% | -2.63% |
Profit Margin | -5.85% | -10.45% | 91.76% | -4.58% | 3.61% | -3.05% |
Free Cash Flow Margin | -6.12% | -0.96% | -2.61% | 0.76% | -9.16% | -29.04% |
EBITDA | 21.5 | 34.3 | 37.1 | 10.4 | 61.1 | 38.5 |
EBITDA Margin | 9.46% | 15.73% | 18.64% | 5.30% | 22.04% | 14.69% |
D&A For EBITDA | 6.7 | 21.5 | 41.1 | 20.7 | 44.8 | 45.4 |
EBIT | 14.8 | 12.8 | -4 | -10.3 | 16.3 | -6.9 |
EBIT Margin | 6.51% | 5.87% | -2.01% | -5.25% | 5.88% | -2.63% |
Effective Tax Rate | - | - | - | - | 18.03% | - |